ArticleJournal of the advanced practitioner in oncology2026

Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.

Maria Rosie Guerrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.